1,841 top medical experts on Chronic Kidney Failure across 76 countries and 45 U.S. states, including 1,746 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Chronic Kidney Failure: The end-stage of chronic renal insufficiency. It is characterized by the severe irreversible kidney damage (as measured by the level of proteinuria) and the reduction in glomerular filtration rate to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require hemodialysis or kidney transplantation.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Chronic Renal Insufficiency (4,701) and Narrower Categories: Frasier Syndrome (119).
  4. Clinical Trials ClinicalTrials.gov : at least 1,703 including 48 Active, 993 Completed, 164 Recruiting
  5. Synonyms: ESRD,  End-Stage Renal Disease,  End-Stage Renal Disease,  Chronic Renal Failure,  End-Stage Renal Failure


  

        

                    


    These expert listings are for individual use without a fee. Biotechs, Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and other organizations may use this only for quick evaluations (no downloads, screen scraping or using the data) to identify the top medical experts for recruiting, advisory panels, boards, and consulting. Please contact us for licensing, customized queries, feedback and questions.

  1. Segev, Dorry L   Surgery   ClinicalTrials.gov Google Publications
    Department of Surgery, Johns Hopkins University School of Medicine, 2000 E Monument Street, Baltimore, MD, 21205, USA. Top Hospital
    Physician  Highly Cited  Highly Published  Guideline  Clinical Trial  Case Reports  Review 
    Relevant US NIH Grant Funding: $777,299 over the last 5 years
    Disclosed payments in 2021 from 41 biomedical companies, totalling $109,317.64, including $93,463.14 from  SANOFI-AVENTIS U.S. LLC
    Subjects: Kidney Failure, Chronic; Kidney Transplantation; Living Donors; Graft Rejection; Postoperative Complications; Renal Dialysis
    Categories: Surgery; Mortality; Statistics & Numerical Data; Adverse Effects; Epidemiology; Methods
    Risk of end-stage renal disease following live kidney donation. (2014)
    KDIGO Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation. (2020)

  2. Chertow, Glenn M   Nephrology   Google Publications
    Division of Nephrology, Department of Medicine, Stanford University School of Medicine, Palo Alto, California. Top Hospital
    Physician  Highly Cited  Highly Published  Clinical Trial  Review 
    Relevant US NIH Grant Funding: $1,157,452 over the last 5 years
    Medicare MIPS (Merit-based Incentive Payment System) rating: 65/100
    Disclosed payments in 2021 from 34 biomedical companies, totalling $379,970.59, including $289,961.26 from  Outset Medical Inc
    Subjects: Kidney Failure, Chronic; Renal Dialysis; Cardiovascular Diseases; Hyperparathyroidism, Secondary; Hemodialysis, Home; Naphthalenes
    Categories: Therapy; Drug Therapy; Therapeutic Use; Methods; Statistics & Numerical Data; Epidemiology
    Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial. (2021)
    US Renal Data System 2020 Annual Data Report: Epidemiology of Kidney Disease in the United States. (2021)

  3. Kovesdy, Csaba Pal   Nephrology   Google Publications
    Division of Nephrology, Department of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
    Physician  Highly Cited  Highly Published  Clinical Trial  Review 
    Relevant US NIH Grant Funding: $1,095,331 over the last 5 years
    Disclosed payments in 2021 from 19 biomedical companies, totalling $28,682.82, including $10,233.82 from  Bayer HealthCare Pharmaceuticals Inc.
    Subjects: Kidney Failure, Chronic; Renal Dialysis; Kidney Transplantation; Peritoneal Dialysis; Inflammation; Cardiovascular Diseases
    Categories: Mortality; Blood; Therapy; Statistics & Numerical Data; Complications; Epidemiology
    Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. (2014)
    Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate. (2016)

  4. Charytan, David M   Nephrology   ClinicalTrials.gov Google Publications
    Division of Nephrology, Department of Medicine, New York University Langone Medical Center, New York, New York, USA.
    Physician  Highly Cited  Clinical Trial  Review 
    Relevant US NIH Grant Funding: $384,547 over the last 5 years
    Medical school: New York University School of Medicine (MD, 1998)
    Medicare Accepted
    Disclosed payments in 2021 from 8 biomedical companies, totalling $11,988.4, including $3,520 from  Novo Nordisk AS
    Subjects: Kidney Failure, Chronic; Renal Dialysis; Death, Sudden, Cardiac; Arrhythmias, Cardiac; Cardiovascular Diseases; Coronary Artery Bypass
    Categories: Therapy; Prevention & Control; Epidemiology; Therapeutic Use; Complications; Methods
    Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy. (2019)
    SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis. (2019)

  5. Agarwal, Rajiv   Nephrology   Google Publications
    Richard L. Roudebush VA Medical Center and Indiana University, Indianapolis, Indiana, USA.
    Physician  Highly Cited  Highly Published  Clinical Trial 
    Relevant US NIH Grant Funding: $2,486,693 over the last 5 years
    Disclosed payments in 2021 from 54 biomedical companies, totalling $105,037.04, including $80,747.33 from  Bayer HealthCare Pharmaceuticals Inc.
    Subjects: Kidney Failure, Chronic; Hypertension; Renal Dialysis; Blood Pressure; Cardiovascular Diseases; Antihypertensive Agents
    Categories: Therapeutic Use; Therapy; Drug Therapy; Complications; Diagnosis; Prevention & Control
    Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy. (2019)
    Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial. (2019)

  6. Levey, Andrew S   Nephrology   Google Publications
    William B. Schwartz Division of Nephrology, Tufts Medical Center, Department of Medicine, Tufts University School of Medicine, Boston, MA.
    Physician  Highly Cited  Highly Published  Clinical Trial  Review 
    Disclosed payments in 2021 from 3 biomedical companies, totalling $6,187.5, including $6,187.5 from  AstraZeneca AB
    Subjects: Kidney Failure, Chronic; Glomerular Filtration Rate; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Albuminuria; Renal Dialysis
    Categories: Blood; Complications; Epidemiology; Mortality; Physiopathology; Etiology
    Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. (2014)
    Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency. (2020)

  7. Mehrotra, Rajnish   Nephrology   ClinicalTrials.gov Google Publications
    Kidney Research Institute, Division of Nephrology, Department of Medicine, University of Washington, Seattle, Washington, USA. Electronic address: . Top Hospital
    Physician  Highly Cited  Highly Published  Clinical Trial  Case Reports  Review 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 72/100
    Subjects: Kidney Failure, Chronic; Renal Dialysis; Peritoneal Dialysis; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Obesity
    Categories: Mortality; Therapy; Blood; Methods; Statistics & Numerical Data; Epidemiology
    Changes in the worldwide epidemiology of peritoneal dialysis. (2017)
    Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. (2019)

  8. Robinson, Bruce M   Nephrology   Google Publications
    Arbor Research Collaborative for Health, Ann Arbor, MI, USA.
    Physician  Highly Cited  Highly Published  Clinical Trial 
    Disclosed payments in 2021 from 2 biomedical companies, totalling $1,036.35, including $1,000 from  Kyowa Kirin Co., Ltd
    Subjects: Kidney Failure, Chronic; Renal Dialysis; Practice Patterns, Physicians; Anemia; Quality of Life; Erythropoietin
    Categories: Therapy; Mortality; Statistics & Numerical Data; Economics; Blood; Epidemiology
    Factors affecting outcomes in patients reaching end-stage kidney disease worldwide: differences in access to renal replacement therapy, modality use, and haemodialysis practices. (2016)
    Projecting ESRD Incidence and Prevalence in the United States through 2030. (2019)

  9. Winkelmayer, Wolfgang C   Nephrology   Google Publications
    Selzman Institute for Kidney Health, Section of Nephrology, Baylor College of Medicine, Houston, Texas. Top Hospital
    Physician  Highly Cited  Highly Published  Clinical Trial  Case Reports  Review 
    Relevant US NIH Grant Funding: $1,862,544 over the last 5 years
    Medicare MIPS (Merit-based Incentive Payment System) rating: 75.8/100
    Disclosed payments in 2021 from 17 biomedical companies, totalling $32,108.53, including $11,477.03 from  Pharmacosmos Therapeutics Inc.
    Subjects: Kidney Failure, Chronic; Renal Dialysis; Atrial Fibrillation; Kidney Transplantation; Anemia; Cardiovascular Diseases
    Categories: Therapy; Epidemiology; Statistics & Numerical Data; Economics; Mortality; Complications
    US Renal Data System 2020 Annual Data Report: Epidemiology of Kidney Disease in the United States. (2021)
    Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. (2019)

  10. Johansen, Kirsten L   Nephrology   ClinicalTrials.gov Google Publications
    Chronic Disease Research Group, Hennepin Healthcare Research Institute, Minneapolis, Minnesota.
    Physician  Highly Cited  Highly Published  Clinical Trial  Review 
    Relevant US NIH Grant Funding: $4,319,647 over the last 5 years
    Disclosed payments from biomedical company (AKEBIA THERAPEUTICS INC) in 2021 for $3,245
    Subjects: Kidney Failure, Chronic; Renal Dialysis; Kidney Transplantation; Frailty; Renal Insufficiency, Chronic; Body Mass Index
    Categories: Therapy; Physiopathology; Epidemiology; Statistics & Numerical Data; Mortality; Complications
    US Renal Data System 2020 Annual Data Report: Epidemiology of Kidney Disease in the United States. (2021)
    Frailty, dialysis initiation, and mortality in end-stage renal disease. (2012)

  11. Grams, Morgan E   Nephrology   Google Publications
    Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland . Top Hospital
    Physician  Highly Cited  Highly Published  Clinical Trial 
    Relevant US NIH Grant Funding: $10,612,613 over the last 5 years
    Subjects: Kidney Failure, Chronic; Kidney Transplantation; Glomerular Filtration Rate; Renal Insufficiency, Chronic; Hypertension; Living Donors
    Categories: Epidemiology; Blood; Statistics & Numerical Data; Mortality; Genetics; Physiopathology
    Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency. (2020)
    Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate. (2016)

  12. Allon, Michael D   Nephrology   Google Publications
    Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama. Top Hospital
    Physician  Highly Cited  Guideline  Clinical Trial  Case Reports 
    Medical school: University of Michigan Medical School (MD, 1982)
    Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 72.3/100
    Disclosed payments in 2021 from 4 biomedical companies, totalling $1,525.66, including $1,462.5 from  Bard Peripheral Vascular, Inc.
    Subjects: Kidney Failure, Chronic; Renal Dialysis; Arteriovenous Shunt, Surgical; Graft Occlusion, Vascular; Catheters, Indwelling; Vascular Access Devices
    Categories: Therapy; Methods; Adverse Effects; Psychology; Statistics & Numerical Data; Prevention & Control
    KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update. (2020)
    Relationships Between Clinical Processes and Arteriovenous Fistula Cannulation and Maturation: A Multicenter Prospective Cohort Study. (2018)

  13. Glickman, Marc H   Vascular Surgery   ClinicalTrials.gov Google Publications
    Eastern Virginia Medical School, Virginia Beach, Virginia.
    Physician  Highly Cited  Guideline  Clinical Trial 
    Subjects: Kidney Failure, Chronic; Renal Dialysis; Arteriovenous Shunt, Surgical; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Vascular Access Devices
    Categories: Therapy; Economics; Instrumentation; Blood Supply; Standards; Adverse Effects
    KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update. (2020)
    Bioengineered human acellular vessels for dialysis access in patients with end-stage renal disease: two phase 2 single-arm trials. (2016)

  14. Vaziri, Nosratola D   Nephrology   Google Publications
    Division of Nephrology, Hypertension and Kidney Transplantation, University of California Irvine School of Medicine, Irvine, California, USA.
    Physician  Highly Cited  Highly Published  Clinical Trial 
    Subjects: Kidney Failure, Chronic; Renal Dialysis; Dyslipidemias; Cardiovascular Diseases; Cholesterol, HDL; Inflammation
    Categories: Metabolism; Blood; Drug Therapy; Therapy; Adverse Effects; Physiopathology
    Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease. (2013)
    Chronic kidney disease alters intestinal microbial flora. (2013)

  15. Inker, Lesley Ann   Internal Medicine   Google Publications
    William B. Schwartz Division of Nephrology, Tufts Medical Center, Department of Medicine, Tufts University School of Medicine, Boston, MA.
    Physician  Highly Cited  Clinical Trial  Review 
    Relevant US NIH Grant Funding: $3,712,891 over the last 5 years
    Medical school: Other (MD, 1997)
    Medicare Accepted
    Subjects: Kidney Failure, Chronic; Glomerular Filtration Rate; Renal Insufficiency, Chronic; Cardiovascular Diseases; Albuminuria; Diabetes Mellitus, Type 2
    Categories: Blood; Mortality; Physiopathology; Epidemiology; Metabolism; Methods
    Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. (2014)
    Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency. (2020)

  16. Gansevoort, Ron T     Google Publications
    Department of Internal Medicine, Nephrology Division, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
    Physician  Highly Cited  Clinical Trial  Review 
    Subjects: Kidney Failure, Chronic; Glomerular Filtration Rate; Albuminuria; Renal Insufficiency, Chronic; Hypertension; Kidney
    Categories: Urine; Mortality; Epidemiology; Etiology; Blood; Diagnosis
    Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. (2014)
    Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency. (2020)

  17. Lee, Timmy Chang   Nephrology   ClinicalTrials.gov Google Publications
    Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama. Top Hospital
    Physician  Highly Cited  Guideline  Review 
    Relevant US NIH Grant Funding: $3,248,801 over the last 5 years
    Medicare MIPS (Merit-based Incentive Payment System) rating: 72.3/100
    Disclosed payments in 2021 from 3 biomedical companies, totalling $7,287.5, including $7,287.5 from  Bard Peripheral Vascular, Inc.
    Subjects: Kidney Failure, Chronic; Renal Dialysis; Arteriovenous Shunt, Surgical; Catheters, Indwelling; Vascular Access Devices; Vascular Grafting
    Categories: Therapy; Methods; Statistics & Numerical Data; Adverse Effects; Economics; Standards
    KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update. (2020)
    Medicare Costs Associated With Arteriovenous Fistulas Among US Hemodialysis Patients. (2018)

  18. Asif, Arif   Nephrology   Google Publications
    Department of Medicine, Jersey Shore University Medical Center, Hackensack-Meridian School of Medicine at Seton Hall University, Hackensack-Meridian Health, Neptune, NJ.
    Physician  Highly Cited  Guideline  Case Reports 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 82/100
    Disclosed payments from biomedical company (Phraxis, Inc.) in 2021 for $12,600
    Subjects: Kidney Failure, Chronic; Renal Dialysis; Arteriovenous Shunt, Surgical; Arrhythmias, Cardiac; Bacteremia; Catheterization, Central Venous
    Categories: Therapy; Methods; Adverse Effects; Complications; Etiology; Epidemiology
    KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update. (2020)
    Innovations in vascular access for hemodialysis. (2019)

  19. Warady, Bradley A   Pediatric Nephrology   Google Publications
    Childrens Mercy, Kansas City, MO.
    Physician  Highly Cited  Highly Published  Guideline  Clinical Trial  Case Reports 
    Relevant US NIH Grant Funding: $4,991,559 over the last 5 years
    Medical school: University of Illinois College of Med (Chi/Peor/Rock/Chm-Urb) (MD, 1979)
    Medicare Accepted
    Disclosed payments in 2021 from 3 biomedical companies, totalling $5,427.5, including $3,400 from  Horizon Therapeutics plc
    Subjects: Kidney Failure, Chronic; Peritoneal Dialysis; Renal Insufficiency, Chronic; Renal Dialysis; Peritonitis; Catheter-Related Infections
    Categories: Therapy; Epidemiology; Adverse Effects; Standards; Blood; Etiology
    Telehealth for Home Dialysis in COVID-19 and Beyond: A Perspective From the American Society of Nephrology COVID-19 Home Dialysis Subcommittee. (2021)
    Predictors of Rapid Progression of Glomerular and Nonglomerular Kidney Disease in Children and Adolescents: The Chronic Kidney Disease in Children (CKiD) Cohort. (2015)

  20. Yevzlin, Alexander S   Nephrology   Google Publications
    Department of Medicine, University of Michigan, Ann Arbor, MI.
    Physician  Highly Cited  Guideline  Case Reports 
    Medical school: Ohio State University College of Medicine (MD, 1998)
    Medicare Accepted
    Disclosed payments in 2021 from 10 biomedical companies, totalling $53,989.23, including $51,899.76 from  Phraxis, Inc.
    Subjects: Kidney Failure, Chronic; Renal Dialysis; Arteriovenous Shunt, Surgical; Nephrology; Blood Vessel Prosthesis Implantation; Cardiac Output, High
    Categories: Methods; Therapy; Adverse Effects; Statistics & Numerical Data; Blood; Diagnosis
    KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update. (2020)
    Initial vascular access type in patients with a failed renal transplant. (2014)

Note:
  1. Only the top 20 experts are shown. You may filter your results or use the geolocation tabs. Contact us to purchase the entire list.
These expert listings are for individual use without a fee. Biotechs, Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and other organizations may use this only for quick evaluations (no downloads or screen scraping) to identify the top medical experts for recruiting, advisory panels, boards, and consulting. Please contact us for licensing, customized queries, feedback and questions.

);